Form 8-K - Current report:
SEC Accession No. 0001213900-21-009269
Filing Date
2021-02-16
Accepted
2021-02-16 08:34:39
Documents
3
Period of Report
2021-02-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea135236-8k_wizepharma.htm 8-K 24888
2 FORM OF WIZE CONVERTIBLE NOTE ea135236ex99-1_wizepharma.htm EX-99.1 128805
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2147
  Complete submission text file 0001213900-21-009269.txt   158055
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 21632859
SIC: 2834 Pharmaceutical Preparations